Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
Fabio MangiacapraLuca PaolucciMichele M ViscusiRoberto MangiacapraPietro M FerraroAnnunziata NuscaRosetta MelfiLeonardo De LucaDomenico GabrielliGian P UssiaFrancesco GrigioniPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
Our analysis shows that HPR on clopidogrel is more frequent in patients with CKD treated with PCI. Patients with HPR are exposed to a high risk of MACE after PCI, regardless of the renal function status.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- risk factors
- chronic kidney disease
- coronary artery bypass
- newly diagnosed
- left ventricular